ANXA1 and neoplasm: Previous studies showed that ANXA1 was involved in the proliferation and invasion of a variety of tumor cells [38, 39], and we also found that downregulated ANXA1 promoted the proliferation of ES cells, which may lead to progression and metastasis in ES patients.